Skip to content

The effect of topical use of sesame oil extracted from tahini (Ardeh) on pain

The effect of topical use of sesame oil extracted from tahini (Ardeh) on pain severity in patients with upper or lower limbs trauma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171017036838N1
Enrollment
120
Registered
2017-12-11
Start date
2016-04-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with traumatic pain. Acute pain

Interventions

The control group uses cooking oil topically
Intervention 1: The intervention group uses sesame oil extracted from tahini (Ardeh) topically. Intervention 2: The control group uses cooking oil topically.
Treatment - Other
Placebo
The intervention group uses sesame oil extracted from tahini (Ardeh) topically

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria are: age range of 15- 40 years; passing at least 1 hour and at most 6 hours from trauma; lack of any sign of bone fractures, internal or external bleeding, dislocation, amputation, presence of a foreign body, nerve damage, fever as well as infection; not using cast or splint at trauma site; having regional pain based on Visual Analog Scale (VAS); lack of any history of addiction, cigarette and alcohol abuse; not receiving drugs or herbal extracts which may interact with the study therapeutic protocol such as anti-coagulants and analgesics; and free from diseases that may a?ect the pain severity such as diabetes, cardiovascular, liver, kidney and musculoskeletal diseases.

Exclusion criteria

Exclusion criteria: Exclusion criteria are: any sign of allergy to the sesame oil or peptic or duodenal ulcers; receiving treatment out of the study like NSAIDs; inappropriate follow up by patients; and patient’s desire to withdraw in any phase of the study.

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: At first day of admission (befor intervention started) and 48 hours later. Method of measurement: Numerous ruler pain.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Gholami

Shiraz University of Medical Sciences

ghom5@yahoo.com+98 71 3647 4278

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026